Bonn, Germany

Susanne Gattner

This inventor holds 1 USPTO granted patent. Top assignees: Katholieke Universiteit Leuven Ku Leuven Research & Development, Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanne Gattner. Retrieved from https://idiyas.com/inventor/susanne-gattner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susanne Gattner: Innovator in Pharmaceutical Research

Introduction

Susanne Gattner is a notable inventor based in Bonn, Germany. She has made significant contributions to the field of pharmaceutical research, particularly in the development of receptor antagonists. Her work focuses on innovative methods for treating diseases associated with specific receptors.

Latest Patents

Susanne Gattner holds 1 patent related to MRGX receptor antagonists. This invention pertains to a method for preventing or treating diseases associated with the MrgX2 receptor. It also includes MrgX2 antagonists and their physiologically acceptable salts. Furthermore, her patent encompasses pharmaceutical compositions and dosage forms that incorporate an MrgX2 antagonist.

Career Highlights

Throughout her career, Susanne has been affiliated with prestigious institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Katholieke Universiteit Leuven (KU Leuven) Research & Development. Her work at these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Susanne Gattner has collaborated with esteemed colleagues, including Christa Müller and Mohamad Wessam Alnouri. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Susanne Gattner's contributions to pharmaceutical research, particularly in the area of MRGX receptor antagonists, highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…